Tim Anderson

Partner, Head of Research, Cowen Healthcare Investments

Tim Anderson is a Partner, Head of Research and a co-founding member of Cowen Healthcare Investments. He focuses on investments in life science and digital medicine companies that have the potential to meaningfully address serious medical conditions. Mr. Anderson is currently a member of the Board of Directors of Cadent Therapeutics, Cullinan Oncology, VectivBio, F2G, and Autobahn. Mr. Anderson previously served as a Board Member or Board Observer of Therachon, Precision Biosciences, Livongo Health, and Compass Therapeutics.  He is also a member of the Investment Committee of Lagunita Biosciences. Prior to his role at Cowen Healthcare Investments, Mr. Anderson was a biotechnology investment banker on Cowen’s healthcare investment banking team. 

Mr. Anderson holds a BA in economics from Bowdoin College.

Get In Touch

Start a conversation with Tim Anderson

Investment Management Team

Our team of dedicated investment professionals seek to capitalize on disruption and dislocation across market, geographies and sectors.

View More
Investment management professional reviews report with a client